Today, the American Cancer Society Cancer Action Network, the American Heart Association, and the Ovarian Cancer National Alliance, in cooperation with Rep. Louise M. Slaughter (D-NY), held a roundtable discussion on the Food and Drug Administration’s (FDA) draft regulatory framework for Laboratory Developed Tests (LDTs).